Relative roles of elastase and reactive oxygen species in the degradation of human glomerular basement membrane by Intact human neutrophils. Glomerular basement membrane (GBM) damage and proteinuria occurring during the early phase of acute glomerulonephritis are often neutrophil (PMN) dependent. The present study sought to identify the potential roles of PMN derived elastase and reactive oxygen species The inclusion of the elastase inhibitors alpha 1 proteinase inhibitor (alPi), and a smaller highly-specific synthetic compound (L658 758), reduced degradation by PMN homogenates by 84.8% and 85.7%, respectively, whereas they were only able to inhibit intact PMN mediated degradation by a maximum of 49.2% and 50.9%, respectively. The inclusion of EDTA (10 mM), an inhibitor of metalloproteinases, reduced GBM degradation by APMA activated and disrupted PMN by only 7.5%. Incubation of PMN with diphenylene iodonium (DPI) abolished PMN reactive oxygen species generation by >95% but preserved elastase release. This compound did not directly affect GBM degradation. It did, however, abolish the inhibitory effect of ROS on alPi activity and thus indirectly reduced GBM damage by up to 20%.
type IV collagen in six hours (8 igfhr) , and underwent a two-hour respiratory burst. The same number of sonically disrupted PMN The inclusion of the elastase inhibitors alpha 1 proteinase inhibitor (alPi), and a smaller highly-specific synthetic compound (L658 758), reduced degradation by PMN homogenates by 84.8% and 85.7%, respectively, whereas they were only able to inhibit intact PMN mediated degradation by a maximum of 49.2% and 50.9%, respectively. The inclusion of EDTA (10 mM), an inhibitor of metalloproteinases, reduced GBM degradation by APMA activated and disrupted PMN by only 7.5%. Incubation of PMN with diphenylene iodonium (DPI) abolished PMN reactive oxygen species generation by >95% but preserved elastase release. This compound did not directly affect GBM degradation. It did, however, abolish the inhibitory effect of ROS on alPi activity and thus indirectly reduced GBM damage by up to 20%.
A number of human and experimental glomerulonephritides are characterized by the infiltration of glomeruli with PMN [l-.4] . Animal models of anti-basement membrane nephritis have highlighted the role of these cells in the pathogenesis of the heterologous phase of proteinuria [5] [6] [7] . The development of proteinuria is thought to reflect glomerular basement membrane (GBM) damage by PMN recruited after antibody binding. This hypothesis is supported by the identification of increased urinary excretion of basement membrane fragments and PMN proteinases by patients with rapidly progressive glomerulonephritis [8] . The destruction of GBM, and its individual components, by PMN has been attributed to their ability to release both reactive oxygen species (ROS) [6] [7] [8] [9] and neutral proteinases [5, [10] [11] [12] [13] during the acute inflammatory response. The relative importance of both mediator systems as direct damaging agents and the role of anti-proteinases is still unresolved [14] [15] [16] [17] . In addition the hypothesis that oxygen radical-mediated inactivation of alPi results in significantly enhanced proteolytic tissue damage remains unproved [14, 16, 18] . Previous studies have used either heterologous systems [19, 20] or non-physiological soluble stimuli such as phorbol myristate acetate (PMA) [14] [15] [16] to investigate the mechanisms of PMN mediated matrix damage. In the present study the role of neutrophils in the pathogenesis of GBM degradation, was studied in an homologous human, intact cell, in vitro model of anti-GBM nephritis to mirror the in vivo pattern of anti-GBM nephritis as closely as possible.
Methods

PMN preparation
Neutrophils were prepared using a modified Ficoll-Paque (Pharmacia LKB Biotechnology, Uppsala, Sweden) density gradient centrifugation technique. Briefly 5 ml aliquots of whole blood were anticoagulated with 0.5 ml citrate solution (170 mt tn-sodium citrate, 75 m citric acid, pH 5.6), layered onto 1 ml dextran 70 solution (6% Dextran 70 in 0.9% NaCI, Baxter, UK) and incubated at 37°C for 45 minutes. The buffy coat was then washed x4 in cold phosphate-buffered saline pH 7.3 (PBS) with a low speed centrifugation (300 x g) in between each wash. The leukocyte pellet was then carefully resuspended in cold PBS, layered onto a Ficoll-Paque density gradient and centrifuged at 400 x g for 35 minutes. After four more washes the remaining erythrocytes in the pellet were lysed in cold 0.2% NaCl. The neutrophils were then washed x3 in PBS. Preparations com-series of decreasing size stainless steel sieves (425, 180, 125, and 90 sm) and washed through with copious amounts of cold PBS. Glomeruli (>95%) were isolated on the 125 pm mesh with tubules and capsular debris on the 90 m sieve. Glomeruli were washed x 4 in cold PBS to remove proteinacious debris and then intrinsic glomerular cells were disrupted in 0.1% Triton X-100 at 37°C for 30 minutes. The resulting homogenate was centrifuged at 200 x g for 15 minutes, washed x4 with PBS, and centrifuged another four times at 3000 x g (5 mm) with washes in distilled water, after which the pellet of GBM was lyophilized. A mean of 30 mg GBM/100 g cortex (range 5 to 80 mg) was obtained and individual preparations were pooled. Microscopic analysis of the prepared GBM revealed typical appearances as previously published [21] and an absence of either cellular or interstitial debris. GBM was free of DNA and judged endotoxin free using a commercially available limulus amoebocyte lysate assay (E-Toxate, Sigma, Poole, UK) [221. There was no evidence of intrinsic proteinase activity within the GBM preparations.
Anti-GBM and normal IgG preparation
Anti-GBM IgG was prepared by Sepharose protein-A affinity chromatography of plasma obtained during the first and second plasmapharesis of a patient with biopsy and serologically proven anti-GBM disease. IgG eluates were titrated to pH 7.4, dialyzed against distilled water, and lyophilized. Normal control human IgG was prepared in an identical manner from pooled normal human serum. Preparations were pure IgG as assessed by SDS-PAGE with silver stain, and were judged endotoxin-free by the limulus amoebocyte lysate assay. IgG immunoreactivity with GBM was assessed by ELISA using a collagenase digest of GBM as the solid phase. Binding of the IgG preparations to GBM was assessed using radiolabeled IgG. Normal and anti-GBM IgG were labeled with 125j using lodobeads (Pierce, Rockford, Illinois, USA) according to the manufacturer's instructions. Approximately I g of anti-GBM IgG bound to each mg of GBM after 16 hours incubation at 37°C and there was no detectable bound normal IgG.
Inhibitors
Human alPi was obtained from Sigma and was dissolved in PBS to the required concentration. L658 758, a highly specific inhibitor of human neutrophil elastase [23] (A gift of Dr. P. Davies Merck Sharp and Dohme, Rahway, New Jersey, USA), was supplied as a white powder and dissolved in PBS to the required concentration. Analar grade ethylene diamine tetra acetic acid (EDTA) was purchased from BDH chemicals. Diphenylene iodonium (DPI; a gift from Prof. 0. Jones, University of Bristol, UK), a potent inhibitor of the PMN NADPH oxidase system which completely abolishes their respiratory burst [24] , was prepared as a stock solution (10 m in dimethyl sulphoxide) and diluted to the required concentration in PBS.
In preliminary experiments the PMN respiratory burst activity was unaffected by proteinase inhibitors and the degranulation of PMN was unaltered by DPI. No inhibitor used with intact PMN reduced their viability as assessed by the release of LDH or their ability to exclude Trypan blue dye. In addition none of the inhibitors were shown to interfere with the assays used in the study.
In vitro model of anti-GBM nephritis
Experiments were performed using a human in vitro model of anti-GBM nephritis. GBM (10 mg) was pre-treated by incubating with pure IgG isolated from either anti-GBM positive plasma or normal serum (1 mg IgG/mg GBM) in Krebs-Ringer phosphate glucose buffer, pH 7.3 (KRPG: Na2HPO4 10 mM, NaH2PO4 2HO 3 mrvi, NaCl 120 mM, KC1 4.8 mri, CaCl2 0.54 mM, MgSO . 7H20 1.2 mi, b D-glucose 11 mM), for 16 hours at 37°C. Following this the GBM was washed three times in KRPG. Normal IgG pre-treated GBM is designated control GBM and GBM pre-treated with anti-GBM IgG is abbreviated GBMIgG*. PMN (5 X 106) were incubated with the control GBM or GBMIgG* (0.5 mg) for varying periods of time in 1 ml KRPG at 37°C. PMN incubated without GBM served as negative controls, and phorbol myristate acetate (PMA 1 sM) was used as an independent, positive control, neutrophil stimulus. Experiments were carried out in a non-agitated system in which neutrophils settled onto the GBM during incubation.
Measurement of GBM collagen IV degradation
The extent of GBM degradation was measured by the release of soluble hydroxyproline containing peptides into the incubation supernatants by a modified chloramine T method [25] . After incubation, the supernatant and pellet were separated by centrifugation for five mm at 4000 x g, made up to a known volume with 0.9% NaC1 and mixed with an equal volume of 12 M HC1. Samples were sealed in glass ampoules and heated for 16 hours at 105°C. The resulting hydrolyzed samples were neutralized alternately with increasingly dilutions of NaOH and HCI. Finally, 100 l of assay buffer (citric acid 0.24 M, glacial acetic acid 6 ml, sodium acetate 0.87 M, sodium hydroxide 0.85 M, pH 6.0) per ml of sample were added. Final volumes were adjusted with 0.9% NaCI and 1 ml removed for hydroxyproline determination. Aliquots were mixed with an equal volume of chioramine T solution (chloramine T 0.35 g, distilled H20 20 ml, 2-methoxyethanol 30 ml, assay buffer 50 ml) at room temperature for five minutes. One ml of an equal mixture of perchloric acid (27 ml of 70% solution in 73 ml distilled H20) and dimethylaminobenzaldehyde (5 g in 100 ml propan-2-ol) was added, mixed thoroughly and heated at 65°C for a further 20 minutes. Hydroxyproline was detected by the development of a pink color measured at 560 nm on a Cecil CE 292 spectrophotometer (Cecil Instruments, Cambridge, UK). Concentrations were determined from a standard curve using pure L-hydroxyproline 0 to 5 g/ml. Results are expressed as the percent total hydroxyproline released by dividing the total supernatant hydroxyproline by the sum of the pellet plus supernatant values for each incubation.
Measurement of PMN activation
Respiratory burst activity. PMN respiratory burst activity was determined over a 120 minute incubation at 37°C by luminol (50 /.LM) enhanced chemilurninescence [26] using a Berthold LB 950 spectrophotometer (Berthold Instruments, St Albans, UK).
PMA (1 M) was used as an independent positive control. PMN degranulation. Degranulation of PMN was measured by published methods for the detection of myeloperoxidase, vitamin B12 binding protein and gelatinase [27] . PMA was used as a positive control for degranulation experiments.
PMN viability
Neutrophil viability during and after incubations was determined by the release of lactate dehydrogenase (LDH). The cells were pelleted by low speed centnfugation (150 X g) and the supernatants assessed for LDH activity in a microtiter plate reader (MR5000/340, Dynatech Laboratories mc, Billingshurst, UK) as described below. Briefly, 150 tI of supernatant were incubated, in triplicate, in a microtiter plate with 20 d, 4.0 mrvi b-nicotinamide adenine dinucleotide (NADH reduced form, Sigma, Poole, UK) and 10 xl, 7.2 m sodium pyruvate for 12 minutes at 25°C. At one minute intervals the optical density of the mixture was measured at 340 nm and the resulting negative optical density gradient calculated. LDH release was calculated as a percentage of the gradient obtained from sonicated PMN prepared on the same day with the same cell preparation.
Cell-free control systems
In addition to the intact cell model, cell free systems were used to assess the efficacy of the elastase inhibitors and the relative contribution of human PMN elastase (HNE) and metalloproteinases to GBM degradation. Briefly either control GBM (0.5 mg) or GBMIgG* (both gave identical results) was incubated for six hours with either sonicated PMN (5 x 106 in KRPG), or pure HNE (10 p.g; a gift from Dr. P. Davies, Merck Sharp and Dohme, Rahway, New Jersey, USA), in the presence of increasing concentrations of two elastase inhibitors, L658 758, a specific low molecular weight compound [23] and alPi. In addition the metallo-ion chelator EDTA was used to assess the PMN content of neutral metalloproteinases both with and without activation of any latent metalloproteinases by APMA (10 mM). Published data indicate that PMN contain a total of -2 jxg elastase per million cells [28] . Ten micrograms of elastase were used in the cell free model to reflect the total available enzyme from the 5 x 106 PMN used in the intact cell system. Degradation of 0.5 mg of GBM in 1 ml of KRPG was assessed by the release of hydroxyproline rich peptides. Inhibitor efficacy was calculated by comparing hydroxyproline release obtained with and without inhibitor.
Statistical analysis
Experiments were carried out in triplicate using PMN from six different donors. The mean data (N 6) were compared using the paired Student's t-test. P values less than 0.05 were considered to be significant. Results 
GBM degradation
Degradation of GBM was determined after incubation periods of up to six hours, since after this time LDH release from PMN rose to supernormal levels (data not shown), indicating loss of cell viability with possible uncontrolled release of intracellular contents.
The mean hydroxyproline release following the interaction of 5 x 106 PMN with GBMIgG* was 10.3 1.1% whereas control GBM only caused 2.3 0.9% release (N = 6; P < 0.05). Degradation of GBMIgG* was dependent on PMN number reaching a maximal degradation of 11.0% using iO PMN. Stimulation of PMN with PMA induced a mean of 24.6% degradation after six hours incubation. Interestingly, although PMA stimulated PMN produced detectable granule markers in the supernatant, when PMN were stimulated by GBMIgG*, basement membrane degradation occurred in the absence of detectable granule markers. PMN incubated in the presence of GBMIgG* produced significantly more degradation at each time point as compared to control GBM (Fig. 1 ).
In the cell free systems GBM degradation by pure PMN elastase was 32.4% after six hours. This was inhibitable by both L658 758 and alPi in a dose-dependent fashion, and both inhibitors were approximately equipotent on a molar basis (Fig.   2 ). Using sonically disrupted PMN, degradation was 22.6% after six hours, and both inhibitors achieved >84% inhibition (Fig. 3) . The metallo-ion chelator EDTA at 10 m or greater concentrations only inhibited degradation of GBM by PMN Chemiluminescence is expressed as integrated counts x l0_6 over a 120-minute incubation period. peak at a mean time of 48 minutes and declining to baseline 10 100 1000 10000 levels after 120 minutes. Both peak and integrated chemiluminescence were substantially greater from PMN incubated with GBMIgG* (Fig. 5) . However, integrated CL over 120 minutes was substantially lower with GBMIgG* as the PMN stimulus than with PMA (Table 1) . Control incubations of neutrophils with both anti-GBM and normal IgG in the absence of GBM did not induce CL.
In the presence of DPI (10 SM), CL was reduced by over 95% (Table 1 ) without affecting either cell viability or degranulation. Normal PMN and those incubated with DPI (10 FM), to abolish ROS production, showed no difference in their ability to degrade the basement membrane collagen. After six hours the mean degradation of GBMIgG* was 9.6 1.1% in the presence of DPI and 9.9 0.9% without it (P = NS). In addition, the degradation of GBM by PMA (1 M) stimulated PMN, which generate 15-fold quantities of ROS when compared to GBMIgG* stimulus (Table 1) , was also unaffected by DPI.
sonicates by up to 6.5% without APMA activation and by 7.5% with APMA (Fig. 3) , and did not enhance the effect of HNE inhibitors. This indicates a relatively low contribution from PMN metalloproteinases in GBM degradation.
When the HNE inhibitors were used with intact PMN stimulated by GBMIgG* the maximal effects of both were markedly reduced. A maximum of only 50% inhibition of GBM degradation could be achieved despite increasing the concentration of both inhibitors to well above that needed to inhibit either all calculated available elastase or >84% PMN granule activity (Fig. 4) .
Reactive oxygen species generation Incubation of PMN with control GBM and GBMIgG* produced a prolonged very low grade respiratory burst, reaching a Interactions between ROS and elastase inhibitors The effects of PMN derived ROS on the function of both elastase inhibitors were studied using normal and DPI treated PMN. The capacity of each inhibitor to reduce GBM degradation by DPI treated PMN was compared to their ability to do the same with normal PMN. The change in elastase inhibitory While DPI treated PMN were able to degranulate and release HNE normally they were unable to generate ROS. Thus, any differences between the effects of DPI treated and normal PMN on the elastase inhibitory capacity of alPi are due to the presence of ROS from the normal PMN. The elastase inhibitory capacity of alPi was significantly reduced by up to 22.7% when it was present in low concentration, the effect becoming less pronounced as alPi concentration increased (Fig. 6 ). In contrast L 658 758 was not significantly affected by ROS (Fig. 6 ).
Discussion
The present study used a homologous in vitro human model of anti-GBM nephritis which allowed analysis of the pathophysiological processes which might lead to in vivo PMN mediated GBM degradation. Damage to the GBM is widely perceived to be the cause of proteinuria during acute glomenilonephritis (GN) [161. The binding of antibody to GBM is followed by intraglornerular accumulation of PMN [5] [6] [7] upon which the early phase of proteinuria is dependent. In the present investigation, solubulization of the principal component of GBM, type IV collagen, was predominantly PMN elastase mediated. Specific elastase inhibitors of differing size significantly ameliorated GBM degradation, though incompletely. Reactive oxygen species did not directly cause GBM degradation but they did reduce the elastase inhibitory capacity of alPi when it was present in low concentrations.
Neutrophil derived ROS [9, 29, 30] and neutral proteinases such as elastase [28, 31] are both thought to be important in the pathogenesis of tissue damage. Previous work has shown that human PMN, when appropriately stimulated have the potential to degrade GBM [10, 19, 20] . Data from these models show a penetrate the cell-substrate milieu and prevent degradation of substrate. In the present study, despite using a 0.4 kD elastase inhibitor (L658 758), no difference in activity was seen compared to the larger alPi. Although effective penetration of the cell-substrate may have occurred there are several reasons why these inhibitors may have been ineffective. Despite using well a 0 .0
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Inhibitor concentration. flM comparable degree of GBM damage to that in our system. However, these models used heterologous anti-whole GBM antibodies [10] , or heterologous antibody sandwiches/immune complexes [19, 20] . In addition, others have used the nonspecific soluble PMN stimulus PMA, whose physiological relevance is unknown. GBM degradation using this stimulus is significantly greater over the same time course both in our model and others. In the present system we used a homologous anti-GBM IgG which recognizes the Goodpasture epitope within the NC-i domain of type IV collagen to provide a close analogy to the in vivo pattern of anti-GBM disease.
The ability of functional neutrophils to induce GBM degradation was only partially ameliorated by elastase inhibitors of 12.5 25 50 100 200 400 two markedly differing sizes. L 658 758 is a 0.4 kD synthetic specific PMN elastase inhibitor, with no activity against other proteinases, from a class of compounds shown to prevent elastase induced lung damage in animals [23] . Alpha 1 Pi, a 51 kD glycoprotein, is the most important natural inhibitor of elastase but also has less potent inhibitory effects on other proteinases [32] . GBM degradation by PMN sonicates and pure HNE were inhibited equally by both L 658 758 and alPi by more than 84% and 94%, respectively. Furthermore, combinations of both inhibitors did not enhance this. Under the same conditions the addition of EDTA, which inhibits metalloproteinases in vitro, only reduced degradation by sonicated PMN by 6 .5% indicating the relatively low activity of metalloproteinases in our system. Further treatment of the PMN sonicates with the organomercurial compound APMA, which has been shown to activate latent metalloproteinases in vitro, only marginally influenced GBM degradation and increased EDTA inhibitable degradation from 6.5% to 7.5%. Interestingly, although PMN metalloproteinases are stored in a latent form, previously published data have shown that following sonication almost all released metalloproteinase is in an active form [27] . These results from the cell free system indicate that up to 84% of GBM degrading activity within PMN may be HNE mediated. The small deficit in GBM degradation not specifically accounted for by either metalloproteinases or HNE may be due to the effects of other relatively minor PMN proteinases such as cathepsin G.
In the intact cell model two effects were seen. Firstly, the degradation of GBM over a six hour period was approximately 50% of maximal achieved by sonicated PMN. The extent of degradation detected with intact PMN was similar to that seen in other models which have used a heterologous antibody stimulus [10] , but much lower than that seen with PMA.
Secondly, the maximal inhibition achieved by both elastase inhibitors was only 50%. This significant decrease in inhibitor efficacy cannot be solely explained by the actions of other PMN enzymes since, as detailed above, sonicated PMN mediated degradation was -84% HNE mediated, with only minor possible contributions from either metalloproteinases or cathepsin G. Previous in vitro studies have suggested that smaller inhibitors such as secretory leukoprotease inhibitor (4 kD) [33] and specific peptide chioromethyl ketones may more effectively
established methodology we were unable to detect any PMN granule contents within the supernatant of the incubations when they were stimulated by GBMIgG*. However, when PMA was used as the PMN stimulus, MPO was clearly detectable in the supernatant (data not shown). Our studies suggest that using an intact cell system the degradation is likely to be focused to the point of PMN-GBM interaction. Thus, under these circumstances the local concentration of HNE may be very high and saturate the capacity of any inhibitors present. In addition HNE is highly cationic and binds to GBM [34] where it remains both active and inaccessible to inhibition by alPi [28] .
The production of ROS by neutrophils is dependent upon the initial formation of superoxide by the membrane bound NADPH-oxidase system [35] , after which hydrogen peroxide (H2O2) [30] and myeloperoxidase catalyzed hypochiorous acid (HOC1) [36] formation may occur. Attempts to clarify the role of ROS in the pathogenesis of tissue damage have yielded conflicting data. Superoxide [6] , H202 [2] , HOC1 [35] and the hydroxyl radical (OH-) [37] have all been implicated in animal models of nephritis. In vitro studies of human PMN-mediated matrix destruction have shown that H2O2 and HOC1 may both be important [15, 16] . However, the use of the soluble neutrophil stimulus PMA in these studies makes interpretation of the data uncertain for several reasons. PMA induces a relatively potent respiratory burst with little degranulation [38, 39] and all PMN in the incubates, including those not in direct contact with substrate, are stimulated. Since PMN in contact with nonphagocytosable surfaces and cells in suspension differ markedly in their response to soluble stimuli [40, 41] , PMA is effectively stimulating different populations of PMN within the same incubation. Thus ROS released from neutrophils in suspension in the presence of PMA may not adequately reflect the in vivo situation. We used chemiluminescence which allows a noninvasive dynamic study of overall PMN respiratory burst activity to be assessed [26] . GBMIgG* produced a long lived, low intensity neutrophil respiratory burst. Total CL activity over the 120 minute incubations using this stimulus produced only 5 to 8% of the activity induced by PMA, further highlighting important differences between the two stimuli. In the present model the compound DPI was used to inhibit PMN respiratory burst activity. DPI binds to, and inhibits, the flavoprotein moiety of the NADPH-oxidase system [24] and renders the PMN incapable of generating superoxide and subsequent ROS including hydrogen peroxide, hydroxyl radicals and hypohalous acids. Despite this, DPI treated PMN can still degranulate normally and remain viable. Functionally, DPI treated neutrophils resemble those of patients with chronic granulomatous disease in whom NADPH-oxidase flavoprotein levels are reduced [24] . The use of DPI has distinct advantages over the use of oxygen radical scavengers and metal ion chelators which have been extensively used to try and dissect out the pathways involved in tissue injury by neutrophils [14-16, 20, 37, 39, 42-44] . These latter compounds can only work after the initial production of superoxide; they are nonspecific in their actions and their efficiency is dependent upon the interaction rate constant between scavenger and radical [14] . Another study, utilizing GBM as the PMN stimulus showed that superoxide was detected only at the site of PMN-substrate contact [45] . Poor penetration of scavengers into this area may further increase their inefficiency. Accordingly, it has been suggested that results obtained with intact cell models which have utilized these agents should be interpreted with caution [14] .
In the absence of a proteinase inhibitor DPI did not affect the ability of neutrophils to digest GBM. This has two main implications. First, there is no evidence that ROS directly caused type IV collagen degradation, though we cannot exclude structural changes which could occur in the absence of soluble products. Second, others have demonstrated that neutrophilderived HOC1 can activate the latent PMN metalloproteinase gelatinase [16, 30] . This was not a significant factor in our acute model since the theoretical increase in GBM degradation expected with normal PMN, as compared to DPI treated cells, was not seen. It is also noteworthy that studies supporting this ROS metalloproteinase activation have used PMA as the neutrophil stimulus [16, 30] which, as mentioned above, may relatively exaggerate the effects of ROS. While this study has failed to demonstrate a significant directly injurious role for ROS against GBM, it does not exclude other potentially damaging effects of these agents in GN. The present model is cell free and therefore does not address the evidence that ROS can injure resident glomerular cells, which could aggravate glomerulonephritis [28, 29, 36, 37] . When the proteinase inhibitors were included in combination with DPI some alteration of local elastase/anti elastase balance was seen. Oxidation of the methionine residue 358, located in the elastase binding site, reduces the inhibitory capacity of alPi over 1000-fold [28] . Carp and Janoff proposed that this could significantly alter proteinase/anti-proteinase balance to favor proteolysis [14] . In the presence of low concentrations of alPi, ROS from GBM-IgG stimulated neutrophils reduced its elastase inhibitory capacity by up to -23%. The loss of this effect at higher concentrations of alPi shows that only small amounts of alPi were oxidized. Weiss and Regiani demonstrated that PMA stimulated neutrophils could reduce alPi efficacy via an H2O2 dependent mechanism by up to 80% [15] , an effect reduced by higher concentrations of alPi. Conversely, Shah, Baricos and Basci showed no such effect using the same stimulus and, furthermore, could not prevent substrate degradation even in the presence of excess alPi [16] . Moreover, Campbell et al have emphasized that the cell-substrate contact during neutrophil activation may be important in limiting the oxidative inactivation of alPi in vivo [17] . Our study shows that using an homologous intact cell system oxidative inhibition of alPi is small but significant.
